[Vitamin D supplementation and COVID-19: expert consensus and guidelines]. / Supplémentation en vitamine D et Covid-19 : consensus d'experts et recommandations.
Geriatr Psychol Neuropsychiatr Vieil
; 19(1): 20-29, 2021 Mar 01.
Article
in French
| MEDLINE | ID: covidwho-992938
ABSTRACT
After 12 months of viral circulation, the SARS-CoV-2 has infected millions of people around the world, leaving hundreds of thousands dead. With the lack of effective therapy and vaccination against COVID-19, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Vitamin D is a possible candidate discussed in a high amount of publications. Randomized clinical trials show that vitamin D supplementation significantly reduces the risk of respiratory infections. There are also many evidences that hypovitaminosis D is an independent (and easily modifiable) risk factor for severe forms of COVID-19 and death. Vitamin D supplementation is a simple, safe and inexpensive measure, which is effective in correcting hypovitaminosis D found in 40-50% of the French population and in more than 80% of adults with COVID-19. In this position paper, we propose simple regimens (adapted to the pharmaceutical forms currently available in France) for vitamin D supplementation in adults with or without COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vitamin D
/
COVID-19 Drug Treatment
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
/
Traditional medicine
/
Vaccines
Limits:
Adult
/
Humans
Country/Region as subject:
Europa
Language:
French
Journal:
Geriatr Psychol Neuropsychiatr Vieil
Year:
2021
Document Type:
Article
Affiliation country:
Pnv.2020.0907
Similar
MEDLINE
...
LILACS
LIS